Royalty Pharma plc - Class A
RPRX
historical activity
| Quarter | Shares | +/- Shares | Change % | Value($) | % of Total value | Avg Report Price($) |
|---|---|---|---|---|---|---|
| Q4 2025 | 17.0M | -363.7K | ↓2.09% | 657.2M | 0.54% | 38.64 |
| Q3 2025 | 17.4M | -648.0K | ↓3.60% | 612.9M | 0.45% | 35.28 |
| Q2 2025 | 18.0M | +4.6M | ↑34.46% | 649.3M | 0.48% | 36.03 |
| Q1 2025 | 13.4M | -732.2K | ↓5.18% | 417.2M | 0.36% | 31.13 |
| Q4 2024 | 14.1M | -2.0M | ↓12.33% | 360.6M | 0.27% | 25.51 |
| Q3 2024 | 16.1M | -230.3K | ↓1.41% | 456.1M | 0.34% | 28.29 |
| Q2 2024 | 16.4M | -310.0K | ↓1.86% | 431.2M | 0.33% | 26.37 |
| Q1 2024 | 16.7M | -927.7K | ↓5.27% | 506.0M | 0.39% | 30.37 |
| Q4 2023 | 17.6M | -650.8K | ↓3.57% | 494.1M | 0.39% | 28.09 |
| Q3 2023 | 18.2M | -259.3K | ↓1.40% | 495.1M | 0.45% | 27.14 |
| Q2 2023 | 18.5M | -418.2K | ↓2.21% | 568.7M | 0.48% | 30.74 |
| Q1 2023 | 18.9M | = | = | 681.6M | 0.61% | 36.03 |